What Was Announced Today
The administration announced new agreements with Eli Lilly and Novo Nordisk that could significantly lower the costs of these medications for some patients. Here’s what you need to know:
For Patients with Medicare:
- Cost could be reduced to $245 per month (with a $50 copay) for Ozempic, Wegovy, Mounjaro, and Zepbound
- These prices are expected to begin around mid-2026 (likely July)
- Not all Medicare patients will qualify – eligibility depends on specific criteria (more on this below)
For Everyone – The TrumpRx Program:
- A new direct-to-consumer website is planned to launch by early 2026
- Prices through this platform would be around $350 per month for injections
- If oral GLP-1 medications are approved in the future (Orforglipron is an investigational, once-daily oral GLP-1 medication being studied for the treatment of type 2 diabetes and obesity), starting doses may be available for $149 per month
What This Means for You Right Now
The most important thing: Nothing changes immediately.
- These new prices won’t be available until 2026 at the earliest
- If you’re currently taking one of these medications, continue as prescribed
- If you’re struggling with costs now, let’s talk about current options and in the future, know more options will be available
What We're Watching
As your physician and advocate, I’m following several questions:
- Insurance landscape: How this might affect commercial insurance coverage going forward. Many of you may currently be receiving medications under your prescription benefit plan.
- The TrumpRx platform: How this direct-purchase option will actually work in practice and will supply keep up with the demand.
What You Should Do Now
✓ Don’t stop your current medication – these changes are still 1-2 years away
✓ Keep your appointments – obesity is a chronic medical condition that needs ongoing management, not just medication
✓ If you’re having trouble affording medication NOW:
- Reach out to our team-
- During office visits we can explore alternative dosing strategies
- We can review whether switching medications makes sense for your situation
✓ If you have questions – reach out to us! That’s what we’re here for.
Remember What Matters Most
Whether these prices go into effect or not, the fundamental truth remains: Obesity is a medical condition, not a character flaw. Effective treatment combines nutrition, movement, behavior modification, medical support, and sometimes medication.
Weight loss medications are powerful tools, but they work best as part of comprehensive care – which is exactly what we provide at Weight Sense.
Stay Informed
This is developing news, and we’ll send updates as:
- More details become available about eligibility criteria
- Florida announces its plans for Medicaid participation
- The timeline becomes clearer
- The TrumpRx platform launches
In the meantime, we’re here for you. Your health journey doesn’t wait for policy changes, and neither do we.
With compassion and commitment to your health,
Dr. Nikita Weight Sense
Orlando, Florida
Questions? Call us at 407-753-5036 or reply to this email.
Weight Sense specializes in personalized, evidence-based, shame-free weight care.
